In the present experiments we have measured the liberation of ['4C]adenosine derivatives and lactate from 'synaptosome beds ' (de Belleroche & Bradford, 1972), prelabelled with [8-14C]adenosine and superfused with glucose/bicarbonate medium with or without metabolic inhibitors and depolarizing agents. To interpret our findings we have also measured ATP, ADP and AMP of the superfused synaptosomes (Barberis & Mcllwain, 1976).
In the present experiments we have measured the liberation of ['4C]adenosine derivatives and lactate from 'synaptosome beds ' (de Belleroche & Bradford, 1972) , prelabelled with [8-14C] adenosine and superfused with glucose/bicarbonate medium with or without metabolic inhibitors and depolarizing agents. To interpret our findings we have also measured ATP, ADP and AMP of the superfused synaptosomes (Barberis & Mcllwain, 1976) .
Superfusion of synaptosomes with fluids containing 3 3 m~-K + gave augmented output of adenosine derivatives and lactate. In the presence of K+, ATP content of synaptosomes decreased and ADP content increased. Such dephosphorylation is reflected by tissue glycolysis, which depends on the degree of phosphorylation of adenine nucleotides and on the inorganic phosphate formed by their breakdown (Lowry et al., 1964) . It can be therefore suggested that the dephosphorylation of ATP could have initiated the output of adenine derivatives.
Sodium cyanide, added in the superfusion fluid of synaptosome beds at a concentration of 2 . 5 m~, increased 3-fold the output of [L4C]adenosine derivatives. This increase in 14C release was concomitant with an increase in lactate output. Again, in the presence of cyanide, synaptosomal ATP content diminished, probably due to the increased I4C release, because ADP and AMP content did not change.
Sodium iodoacetate, at a concentration of 2 . 5 m~, also increased the release of
[14C]adenosine derivatives, by 4-fold, but in this case the lactate output was inhibited and ATP content and total nucleotides were diminished.
In the presence of ouabain at a concentration of O . l m~, the output of adenosine derivatives increased by 3-fold when the release of lactate was poorly affected.
Nevertheless, synaptosomal ATP content decreased and ADP content increased. Veratridine, at a concentration of ~O P M , increased 4-fold the output of adenosine derivatives and that of lactate. This was accompanied by a great fall in synaptosomal ATP content, and ADP content increased.
From these results it is concluded that the release of adenosine derivatives by synaptosomal preparations, in the presence of metabolic inhibitors or depolarizing agents, was not due to a modification of the tissue's energy metabolism, but to other more specific causes, which affect the metabolism of adenosine derivatives themselves.
This research was supported by grants from the Centre National de la Recherche Scientifique (E.R.A. 331) (19766) , however, have reported the esterification of long-chain (>Czz) fatty acids to cholesterol in ALD brain and adrenals. Several unknown compounds, presumably also containing carboxy groups, were also reportedly esterified. The fatty acids of brain gangliosides have also been found to be enriched in long-chain acids (Igarashi et al., 1976u) , but the same is not true of the brain galactolipids (Ramsey et al., 1977) .
Using methods and patients previously described (Ramsey et a]., 1976,1977) , we have been able to confirm the presence of long-chain fatty acids esterified to cholesterol in ALD brain. We had also previously reported the presence of an appreciable free fatty acid fraction in ALD brain (Ramsey et ul., 1976) . Upon further investigation, we have observed compounds with the t.1.c. mobility of triacylcerols in brain white and grey matter, as well as myelin and related fractions ( Table 1) . Because of the uncertain nature of the fatty acids involved, quantification has been by charring of the t.1.c. plate followed by densitometry only.
When these neutral lipids were examined by g.l.c., long-chain fatty acids were found in all neutral lipid classes (Table 2) . Several major peaks could not be readily characterized by g.1.c. retention times alone. These compounds are presently under further investigation.
A report by Ogino et al. (1978)
has indicated that ALD brain is not deficient in the enzymes necessary for cholesteryl ester synthesis or degradation. We have found that * Abbreviation: ALD, adrenoleukodystrophy. cholesterol is the only major sterol in ALD brain (Ramsey et al., 1976) . In view of the previous and present observations, it would appear that the fatty acid moiety is the major abnormal component of ALD brain cholesteryl esters, gangliosides, triacylglycerols and non-esterified fatty acids. The aberrant metabolism of these fatty acids would therefore seem pivotal to the pathogenesis of adrenoleukodystrophy.
This research was supported, in part, by NATO research grant no. The intracerebral accumulation of glycogen that occurs during the period of seizures induced in the mouse by administration of L-methionine m-sulphoximine, and that persists up to 72h after intraperitoneal injection of the drug (Folbergrova et al., 1969; Folbergrova, 1973) , is prevented by the simultaneous injection of metyrapone, an inhibitor of 1 ID-hydroxylase catalysing cortisol synthesis in the adrenal cortex (Berel et al., 1977) , but is only partially prevented in adrenalectomized mice (A. BerelCosset, P. R. Lehr & J. Gayet, unpublished work). It has been suggested (Berel et al., 1977) that the ultrastructural damages observed in the brain after L-methionine DLsulphoximine administration (De Robertis, 1971 ) may well be the primary cause of the long-term accumulation of glycogen, within swollen astrocytes (Phelps, 1975) , by an activation of gluconeogenesis, probably through regulation by glucocorticoids. Although brain had been considered as a non-gluconeogenic organ (Scrutton & Utter, 1968) , it has been shown recently in guinea-pig brain slices that gluconeogenesis may proceed from pyruvate and glutamate, with evidence of fructose 1,6-bisphosphatase (EC 3.1.3.1 1) activity (Phillips & Coxon, 1975) ; moreover, the presence of this key gluconeogenic enzyme in the rat brain was proved unequivocally (Majumder & Eisenberg, 1977) .
Since the control point in glycolysis in the brain must occur particularly at the phosphofructokinase (EC 2.7.1.1 1) step (Lowry et al., 1964) , the activation of gluconeogenesis or inhibition of glycolysis can be effected either by stimulation of fructose 1,6-bisphosphatase or inhibition of phosphofructokinase. The effect of L-methionine DL-sulphoximine, administered to the male Swiss mouse, on the activity of these two enzymes in the cerebral cortex, brain stem, and cerebellum has been studied to show whether the cerebral accumulation of glycogen induced by the convulsant originates from an activation of gluconeogenesis. Fructose 1,6-bisphosphatase, devoid of hexose 6-phosphate and of glucose 6-phosphatase and phosphofructokinase activities, was prepared from a brain-tissue homogenate as described by Underwood & Newsholme (1965) , and assayed with the coupled spectrophotometric method of Latzko & Gibbs (1974) ; the activity of fructose 1,6-bisphosphatase was expressed as pmol of fructose 1,6-bisphosphate hydrolysed/min per g of tissue wet wt. at 37°C. Phosphofructokinase was prepared from a brain-tissue homogenate and was assayed spectrophotometrically by an adaptation of the procedures of Newsholme e t a / . (1977) ; the activity of phosphofructokinase was expressed as pmol of fructose 6-phosphate phosphorylated/min
